Pfizer Inc., the world's biggest drugmaker, won U.S. approval for maraviroc, the first new type of medicine in a decade to treat the virus that causes AIDS, sending the company's shares to their biggest gain in more than a year.
The FDA found no unusual deaths tied to maraviroc. People who took the drug were more likely to develop flu-like illnesses or herpes. The product's prescribing information includes a boxed warning about liver damage and a statement about the possibility of heart attacks, the FDA said in a statement read more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment